HAL vs NTLA · P/E 9.3, $19.05B cap vs rev $57.9M
Halliburton Company (HAL) versus Intellia Therapeutics Inc (NTLA) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Intellia Therapeutics Inc (NTLA) is a biotechnology company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported NTLA revenue for 2024-12-31 was $57.9M. Net income was -$519.0M. Revenue was up 59.6% from 2023-12-31 to 2024-12-31. NTLA currently screens at market cap $1.19B.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. NTLA currently screens at market cap $1.19B.
Not investment advice. Open the HAL and NTLA stock pages for the full models.
Not investment advice.